These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11454144)

  • 1. Chlamydia pneumoniae and luminal narrowing after coronary angioplasty.
    Mattila KJ; Juvonen JT; Kotamäki MK; Saikku PA
    J Intern Med; 2001 Jul; 250(1):67-71. PubMed ID: 11454144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary angioplasty induces rise in Chlamydia pneumoniae-specific antibodies.
    Tiran A; Tio RA; Ossewaarde JM; Tiran B; den Heijer P; The TH; Wilders-Truschnig MM
    J Clin Microbiol; 1999 Apr; 37(4):1013-7. PubMed ID: 10074519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologic response to gain and loss in coronary minimal luminal diameter in patients treated with coronary angioplasty: prediction of restenosis on the basis of exercise capacity.
    Jørgensen B; Simonsen S; Endresen K; Forfang K; Egeland T; Thaulow E
    Am Heart J; 2000 Mar; 139(3):482-90. PubMed ID: 10689263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prior cytomegalovirus, Chlamydia pneumoniae or Helicobacter pylori infection and the risk of restenosis after percutaneous transluminal coronary angioplasty.
    Carlsson J; Miketic S; Brom J; Ross R; Bachmann H; Tebbe U
    Int J Cardiol; 2000 Apr; 73(2):165-71. PubMed ID: 10817856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlamydia pneumoniae seropositivity predicts the risk of restenosis after percutaneous transluminal coronary angioplasty.
    Hayashida K; Tanaka M; Morita H; Hayashi F; Inada T; Suzuki H; Sakamoto T; Katsuragawa M; Hibino H; Kambara H
    Heart Vessels; 2002 May; 16(4):137-45. PubMed ID: 12224784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in antibody titers against Chlamydia pneumoniae after coronary angioplasty.
    Yetkin G; Yetkin E; Aksoy Y; Gurbuz OA; Mert A
    Int J Cardiol; 2004 Jun; 95(2-3):293-7. PubMed ID: 15193835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of chlamydia pneumoniae antibodies in patients with coronary heart disease].
    Podsiadły E; Kruk M; Przyłuski J; Deptuch T; Ruzyłło W; Tylewska-Wierzbanowska S
    Przegl Epidemiol; 2001; 55(3):253-60. PubMed ID: 11761832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
    J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prior restenosis predicts restenosis after coronary angioplasty of a new significant narrowing.
    Bresee SJ; Jacobs AK; Garber GR; Ruocco NA; Mills RM; Bergelson BA; Ryan TJ; Faxon DP
    Am J Cardiol; 1991 Nov; 68(11):1158-62. PubMed ID: 1951074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luminal narrowing after percutaneous transluminal coronary angioplasty. A multivariate analysis of clinical, procedural and lesion related factors affecting long-term angiographic outcome in the PARK study. Post-Angioplasty Restenosis Ketanserin.
    Melkert R; Violaris AG; Serruys PW
    J Invasive Cardiol; 1994 Jun; 6(5):160-71. PubMed ID: 10155065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlamydia pneumoniae infection and restenosis in patients with coronary heart disease.
    Krausse R; Leiendecker J; Herrmann G; Harder T; Ullmann U
    Infection; 2003 Jun; 31(3):149-54. PubMed ID: 12789472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle.
    Gallo R; Padurean A; Jayaraman T; Marx S; Roque M; Adelman S; Chesebro J; Fallon J; Fuster V; Marks A; Badimon JJ
    Circulation; 1999 Apr; 99(16):2164-70. PubMed ID: 10217658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty.
    Foley DP; Melkert R; Serruys PW
    Circulation; 1994 Sep; 90(3):1239-51. PubMed ID: 8087933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of late proven patency after successful coronary angioplasty.
    Weintraub WS; Ghazzal ZM; Cohen CL; Douglas JS; Liberman H; Morris DC; King SB
    Circulation; 1991 Aug; 84(2):572-82. PubMed ID: 1860202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group.
    Rensing BJ; Hermans WR; Vos J; Tijssen JG; Rutch W; Danchin N; Heyndrickx GR; Mast EG; Wijns W; Serruys PW
    Circulation; 1993 Sep; 88(3):975-85. PubMed ID: 8353925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of continued smoking and some biological risk factors on restenosis after percutaneous transluminal coronary angioplasty.
    Kotamäki M; Laustiola K; Syvänne M; Heikkilä J
    J Intern Med; 1996 Nov; 240(5):293-301. PubMed ID: 8946812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues.
    Campbell LA; O'Brien ER; Cappuccio AL; Kuo CC; Wang SP; Stewart D; Patton DL; Cummings PK; Grayston JT
    J Infect Dis; 1995 Aug; 172(2):585-8. PubMed ID: 7622912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlamydia pneumoniae infection and incident coronary heart disease: the Atherosclerosis Risk in Communities Study.
    Nieto FJ; Folsom AR; Sorlie PD; Grayston JT; Wang SP; Chambless LE
    Am J Epidemiol; 1999 Jul; 150(2):149-56. PubMed ID: 10412959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups.
    Foley DP; Melkert R; Umans VA; de Jaegere PP; Strikwerda S; de Feyter PJ; Serruys PW
    Eur Heart J; 1995 Oct; 16(10):1331-46. PubMed ID: 8746901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vessel wall changes in the proximal non-treated segment after PTCA. An in vivo intracoronary ultrasound study.
    Zamorano J; Erbel R; Ge J; Görge G; Kearney P; Scholte A; Meyer J
    Eur Heart J; 1994 Nov; 15(11):1505-11. PubMed ID: 7835366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.